211 related articles for article (PubMed ID: 26446857)
1. Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant.
Zhang X; Wang M; Li P; Wang A; Liang R; Gai Y; Liu W; Li Y; Sun K
Pharm Dev Technol; 2016 Dec; 21(8):1006-1014. PubMed ID: 26446857
[TBL] [Abstract][Full Text] [Related]
2. Controlled porosity solubility modulated osmotic pump tablets of gliclazide.
Banerjee A; Verma PR; Gore S
AAPS PharmSciTech; 2015 Jun; 16(3):554-68. PubMed ID: 25378281
[TBL] [Abstract][Full Text] [Related]
3. Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery.
Pan H; Jing H; Yang X; Pan W; Chen T
Drug Dev Ind Pharm; 2017 May; 43(5):780-788. PubMed ID: 27278057
[TBL] [Abstract][Full Text] [Related]
4. A two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniques.
Liu X; Wang S; Chai L; Zhang D; Sun Y; Xu L; Sun J
Int J Pharm; 2014 Jan; 461(1-2):529-39. PubMed ID: 24374219
[TBL] [Abstract][Full Text] [Related]
5. Preparation, release and pharmacokinetics of a risperidone elementary osmotic pump system.
Gong W; Liu Y; Mei DY; Yang M; Mei XG
Drug Dev Ind Pharm; 2015 Mar; 41(3):464-9. PubMed ID: 24400982
[TBL] [Abstract][Full Text] [Related]
6. Preparation and
Li N; Fan L; Wu B; Dai G; Jiang C; Guo Y; Wang D
Drug Dev Ind Pharm; 2019 Jul; 45(7):1079-1088. PubMed ID: 30909753
[TBL] [Abstract][Full Text] [Related]
7. A novel osmotic pump-based controlled delivery system consisting of pH-modulated solid dispersion for poorly soluble drug flurbiprofen: in vitro and in vivo evaluation.
Li S; Wang X; Wang Y; Zhao Q; Zhang L; Yang X; Liu D; Pan W
Drug Dev Ind Pharm; 2015; 41(12):2089-99. PubMed ID: 26304493
[TBL] [Abstract][Full Text] [Related]
8. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting the release of nifedipine from a swellable elementary osmotic pump.
Nokhodchi A; Momin MN; Shokri J; Shahsavari M; Rashidi PA
Drug Deliv; 2008 Jan; 15(1):43-8. PubMed ID: 18197523
[TBL] [Abstract][Full Text] [Related]
10. Development of controlled release osmotic pump tablet of glipizide solid dispersion.
Patel GC; Asodaria KV; Patel HP; Shah DR
Curr Drug Deliv; 2014; 11(6):817-27. PubMed ID: 23859357
[TBL] [Abstract][Full Text] [Related]
11. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterisation of Kolliphor® P 188 and P 237 solid dispersion oral tablets containing the poorly water soluble drug disulfiram.
Ramadhani N; Shabir M; McConville C
Int J Pharm; 2014 Nov; 475(1-2):514-22. PubMed ID: 25218186
[TBL] [Abstract][Full Text] [Related]
13. A novel asymmetric membrane osmotic pump capsule with in situ formed delivery orifices for controlled release of gliclazide solid dispersion system.
Yang Y; Zhao Z; Wang Y; Yang L; Liu D; Yang X; Pan W
Int J Pharm; 2016 Jun; 506(1-2):340-50. PubMed ID: 27132166
[TBL] [Abstract][Full Text] [Related]
14. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.
Yanfei M; Guoguang C; Lili R; Pingkai O
Drug Dev Ind Pharm; 2015; 41(8):1353-62. PubMed ID: 25138348
[TBL] [Abstract][Full Text] [Related]
16. Development and Evaluation of a Once-Daily Controlled Porosity Osmotic Pump of Tapentadol Hydrochloride.
Thakkar HP; Pancholi N; Patel CV
AAPS PharmSciTech; 2016 Oct; 17(5):1248-60. PubMed ID: 26677859
[TBL] [Abstract][Full Text] [Related]
17. Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation.
Liu D; Yu S; Zhu Z; Lyu C; Bai C; Ge H; Yang X; Pan W
Int J Pharm; 2014 Nov; 475(1-2):496-503. PubMed ID: 25219321
[TBL] [Abstract][Full Text] [Related]
18. Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability.
Alam N; Beg S; Rizwan M; Ahmad A; Ahmad FJ; Ali A; Aqil M
Drug Dev Ind Pharm; 2015 Apr; 41(4):692-702. PubMed ID: 24669975
[TBL] [Abstract][Full Text] [Related]
19. [Application research of hot-melt extrusion in preparation of solid dispersion].
Chen MW; Chen WR; Chen TK; Chen RE; Wang YT
Yao Xue Xue Bao; 2012 Feb; 47(2):163-7. PubMed ID: 22512025
[TBL] [Abstract][Full Text] [Related]
20. Design and Evaluation of Bilayer Pump Tablet of Flurbiprofen Solid Dispersion for Zero-Order Controlled Delivery.
Cheng L; Li T; Dong L; Wang X; Huo Q; Wang H; Jiang Z; Shan X; Pan W; Yang X
J Pharm Sci; 2018 May; 107(5):1434-1442. PubMed ID: 29291415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
